Plasma exchange removes glycosphingolipid in Fabry disease

R. E. Pyeritz; M. D. Ullman; A. B. Moser; H. G. Braine; H. W. Moser

doi:10.1002/ajmg.1320070308

Plasma exchange removes glycosphingolipid in Fabry disease

R. E. Pyeritz, M. D. Ullman, A. B. Moser, H. G. Braine, H. W. Moser

School of Medicine

Research output: Contribution to journal › Article › peer-review

12 Scopus citations

Abstract

In a man with Fabry disease, basal plasma glycosphingolipid (GSL) levels were determined by high-performance liquid chromatography (HPLC). A series of three alternate-day plasma exchanges transiently lowered plasma ceramide trihexoside (CTH) to normal. A total of 70 μmoles of CTH were removed by eight plasma exchanges. If future studies show that pathologic tissue accumulations of CTK are reduced by plasma exchange, then long-term repetitive plasma exchange could be used as treatment until enzyme replacement is practical.

Original language	English (US)
Pages (from-to)	301-307
Number of pages	7
Journal	Unknown Journal
Volume	7
Issue number	3
DOIs	https://doi.org/10.1002/ajmg.1320070308
State	Published - 1980

ASJC Scopus subject areas

Genetics(clinical)

Access to Document

10.1002/ajmg.1320070308

Cite this

@article{e407f45da17f4bd993450a3d882d7f08,

title = "Plasma exchange removes glycosphingolipid in Fabry disease",

abstract = "In a man with Fabry disease, basal plasma glycosphingolipid (GSL) levels were determined by high-performance liquid chromatography (HPLC). A series of three alternate-day plasma exchanges transiently lowered plasma ceramide trihexoside (CTH) to normal. A total of 70 μmoles of CTH were removed by eight plasma exchanges. If future studies show that pathologic tissue accumulations of CTK are reduced by plasma exchange, then long-term repetitive plasma exchange could be used as treatment until enzyme replacement is practical.",

author = "Pyeritz, {R. E.} and Ullman, {M. D.} and Moser, {A. B.} and Braine, {H. G.} and Moser, {H. W.}",

year = "1980",

doi = "10.1002/ajmg.1320070308",

language = "English (US)",

volume = "7",

pages = "301--307",

journal = "Unknown Journal",

issn = "0309-1708",

publisher = "Elsevier Ltd",

number = "3",

}

TY - JOUR

T1 - Plasma exchange removes glycosphingolipid in Fabry disease

AU - Pyeritz, R. E.

AU - Ullman, M. D.

AU - Moser, A. B.

AU - Braine, H. G.

AU - Moser, H. W.

PY - 1980

Y1 - 1980

N2 - In a man with Fabry disease, basal plasma glycosphingolipid (GSL) levels were determined by high-performance liquid chromatography (HPLC). A series of three alternate-day plasma exchanges transiently lowered plasma ceramide trihexoside (CTH) to normal. A total of 70 μmoles of CTH were removed by eight plasma exchanges. If future studies show that pathologic tissue accumulations of CTK are reduced by plasma exchange, then long-term repetitive plasma exchange could be used as treatment until enzyme replacement is practical.

AB - In a man with Fabry disease, basal plasma glycosphingolipid (GSL) levels were determined by high-performance liquid chromatography (HPLC). A series of three alternate-day plasma exchanges transiently lowered plasma ceramide trihexoside (CTH) to normal. A total of 70 μmoles of CTH were removed by eight plasma exchanges. If future studies show that pathologic tissue accumulations of CTK are reduced by plasma exchange, then long-term repetitive plasma exchange could be used as treatment until enzyme replacement is practical.

UR - http://www.scopus.com/inward/record.url?scp=0019173928&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019173928&partnerID=8YFLogxK

U2 - 10.1002/ajmg.1320070308

DO - 10.1002/ajmg.1320070308

M3 - Article

C2 - 6781344

AN - SCOPUS:0019173928

SN - 0309-1708

VL - 7

SP - 301

EP - 307

JO - Unknown Journal

JF - Unknown Journal

IS - 3

ER -

Plasma exchange removes glycosphingolipid in Fabry disease

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this